These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 2643499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I, Boubred F, Simeoni U.
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.
    Knight DB.
    Semin Neonatol; 2001 Feb; 6(1):63-73. PubMed ID: 11162286
    [Abstract] [Full Text] [Related]

  • 8. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S, Limrungsikul A, Khowsathit P.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Patent ductus arteriosus. A common clinical problem in extremely premature infants].
    Edstedt-Bonamy AK, Johansson S, Milerad J.
    Lakartidningen; 2000 Dec 06; 97(49):5756-61. PubMed ID: 11188032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S, Khowsathit P, Patchakapati B.
    J Med Assoc Thai; 1999 Nov 06; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A, Strehl R, Barth H, Seyberth HW.
    Acta Paediatr; 2004 Feb 06; 93(2):233-40. PubMed ID: 15046280
    [Abstract] [Full Text] [Related]

  • 17. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
    Monset-Couchard M, Dias-Mançano D, Murat I, Relier JP.
    Pediatrie; 1983 Sep 06; 38(6):365-77. PubMed ID: 6364030
    [Abstract] [Full Text] [Related]

  • 18. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M, Bose C, Clark R.
    J Perinatol; 2007 Mar 06; 27(3):164-70. PubMed ID: 17251985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical profile and management of symptomatic patent ductus arteriosus in premature infants.
    Shenoi A, Narang A, Bhakoo ON, Bidwai PS.
    Indian Pediatr; 1991 Feb 06; 28(2):125-30. PubMed ID: 2055626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.